Revvity Inc.
USUSDRevvity Inc. (XETRA:PKN) — Biotechnology: Laboratory Analytical Instruments. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 3. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
Ettevõtte Kohta
- Veebileht
- revvity.com
- Investorite Suhted
- ir.revvity.com/home/default.aspx
- Sektor
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Peakontor
- Waltham, United States
- Tegevjuht
- Prahlad R. Singh
- Töötajad
- 11 000
- Ringluses Olevad Aktsiad
- 111.59 mln seisuga 2026-08-06
- Vabalt Kaubeldavad Aktsiad
- 102.49 mln
- Turukapitalisatsioon
- 16.63 mld USD
- Siseringi Isikud
- 0.26%
- Institutsionaalsed Investorid
- 96.55%
- Tegevusala (SIC)
- Laboratory Analytical Instruments
- Õiguslik Vorm
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- P/E
- 70.1
- Väljamaksesuhe
- 13.4%
- FCF
- 558 mln USD
- Väljamakse / FCF
- 6%
- Võlg
- 3.21 mld USD3.9 a FCF
- Dividendistaaž
- 43 a
- Kasum, FCF ja dividendid makstud — 12 kuu jooksul kuni 05.07.2026 (ettevõtte viimane raport).
- NAV
Kirjeldus
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividendid
Revvity Inc. (RVTY) maksab dividende kvartalis. Aastas (12 kuud kuni viimase teatatud maksega): 0.28 USD aktsia kohta (maksed: 4). See on umbes 0.18% praegusest aktsiahinnast. Järgmine ex-dividend kuupäev on 23.10.2026: 0.07 USD aktsia kohta, väljamakse 13.11.2026. Katkematu dividendiajalugu: 43 aastat.
| Ex-Kuupäev | Väljamakse | Summa | % | Tüüp | Tikker |
|---|---|---|---|---|---|
| 2026-10-23 välja kuulutatud | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | kord kvartalis | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.1/0.3 % | kord kvartalis | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.1/0.3 % | kord kvartalis | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.1/0.2 % | kord kvartalis | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.1/0.3 % | kord kvartalis | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.1/0.3 % | kord kvartalis | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.1/0.3 % | kord kvartalis | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.1/0.2 % | kord kvartalis | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.1/0.2 % | kord kvartalis | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/≈0.2 % | kord kvartalis | US:RVTY |
| 2024-04-18 | 2024-05-10 | 0.0700 USD | 0.0/≈0.2 % | kord kvartalis | US:RVTY |
| 2024-01-18 | 2024-02-09 | 0.0700 USD | 0.0/≈0.2 % | kord kvartalis | US:RVTY |
Suurimad Omanikud
| Omanik | Osalus | Aktsiad | Aruande Kuupäev |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 mln | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 mln | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 mln | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 mln | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 mln | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 mln | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 mln | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 mln | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 mln | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 mln | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 mln | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 mln | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 mln | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 mln | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 mln | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 mln | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 mln | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
Logi Sisse Google